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Interactions among macrophages  (M¢),1 T  cells,  and precursors of antibody-producing 
(B)  cells in the presence of antigen, mediated by direct cell-to-cell contact(s) and/or by 
soluble factors  elaborated by one or more of the cells, are essential for development of 
optimal plaque-forming cell  (PFC)  responses to  "thymus-dependent" antigens such as 
sheep  erythrocytes  (SRBC)  and random terpolymer of L-glutamic acid6°-L-alanine3°-L  - 
tyrosine  ~° (GAT) by mouse spleen ceils in vitro (1-4). Recent experiments have defined 
some of the genetic requirements for successful physiologic interactions among antigen 
and these cells. First, M~b and lymphoid cells (T and B  cells) need not be syngeneic for 
successful generation of PFC responses; allogeneic M~ support the development of PFC 
responses  by  lymphoid cells  which  are  comparable  in  magnitude to  responses  which 
develop in the presence of syngeneic M~b (4-6). Thus no known genetic restrictions appear 
to govern the interactions of MO with T  cells and B cells in the development of antibody 
responses in the mouse. Second, physiologic cooperation between T  and B  ceils requires 
that the T cells be syngeneic or semisyngeneic  with B cells at the H-2 complex (7, reviewed 
in reference 8). It has been shown that identity of certain membrane molecules encoded by 
the  H-2  complex  is  required  for  antigen-activated T  cells  to  be  able  to  supply  the 
appropriate "second" stimulus required to trigger antigen-activated B cells into cycles of 
cell division and differentiation into mature antibody-producing cells. These membrane 
molecules may be the H-2 antigens themselves or other molecules coded for by the K  end 
of the H-2 complex (8). In addition to the mechanism of T-cell-B-cell  interaction requiring 
physical contact between crucial membrane molecules on T  and B cells, humoral factors 
produced by activated T  cells may also act on the  membrane molecules on B  cells to 
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provide  the appropriate  second stimulus  (8,  9).  Thus,  gene products of the H-2 complex 
located  on  the  membranes  of  the  T  and  B  cells  play  a  crucial  role  in  the  successful 
generation of antibody  responses. 
We  have  used  the  suppressive  effects  of alloantisera  against  leukocyte  alloanti- 
gens  on  PFC  responses  in  vitro  as  a  model  system  to  investigate  which  of  the 
required  interactions  among  antigen,  Me,  T  cells,  and  B  cells  may  be  mediated 
by  membrane  molecules  coded  fbr by the H-2 complex.  In this communication  we 
shall define  some  of the  important  parameters  in suppression  of PFC  responses  in 
vitro by antisera  against  leukocyte  alloantigens  and  the  cellular  sites of action  of 
suppressive  alloantisera. 
Materials and Methods 
Mice.  C57BL/6 (H-2~),  SJL/J (H-2~),  A/J (H-2~), DBA/2J (H-2~), C3H/HeJ (H-2~), and B10.D2n 
(H-2  ~) male mice were purchased from Jackson Laboratories, Bar Harbor, Maine. A.Sw (H-2  ~) male 
mice were purchased from Dr. G. Haughton, University of North Carolina, Chapel Hill, N.C.;  B10.S 
(H-2  s)  male mice were produced  in our animal thcilities from breeding stock from Dr. D.  Shreffler, 
University of Michigan, Ann Arbor, Mich. The F1 hybrid mice of (C57BL/6  ×  SJL) (H-2~Js), (B10.A 
×  B10.S)  (H-2~J~), and (C57BL/6  ×  B10.S) (H-2  bs)  matings were produced  in our animal facilities. 
Mice used in these studies were 3- to 6-mo old and were maintained on acidified-chlorinated water and 
laboratory chow ad libitum. 
Antigens.  SRBC  (Grand Island Biological  Co.,  Grand Island,  N.  Y.)  were prepared for use as 
antigen in cultures or as indicator cells in the hemolytic plaque assay as described previously (10). A 
sterile stock solution of 10 mg GAT/ml (Miles Laboratories, Inc., Miles Research Div., Kankakee, Ill.) 
with an average mol wt of 32,000 was prepared and diluted for addition to cultures as antigen or for 
preparation of GAT-SRBC for indicator cells in the hemolytic plaque assay as described previously 
(11). 
Alloantisera.  Four  polyspecific  alloantisera,  DBA/2  anti-C57BL/6;  C3H/He  anti-SJL;  SJL 
anti-C57BL/6; and  C57BL/6 anti-SJL, were prepared in our laboratory by injecting recipient mice 
intraperitoneally (i.p.) at 2-wk intervals with 25  ×  106 spleen cells from donor mice. 7 days after the 
eighth and subsequent injections, recipient mice were bled and the serum was separated and stored at 
20°C.  Alloantisera with activity against antigens coded for by defined regions of the H-2 complex 
were  gifts from Dr. D.  Shreffler and Dr.  G.  Snell (Jackson Laboratories). The strain combinations 
used  in  the  production of these sera  and the specificities against which the sera  are  reactive are 
detailed in Table II. All alloantisera were decomplemented by heating at 56°C for 30 min, absorbed 
three times at 4°C with SRBC equivalent to 20% of the volume of serum, and centrifuged at 40,000 
rpm  for  2  h  at  0°C  in  a  SW  50.1  rotor  in  a  Beckman  Model  L3-50  ultracentrifuge  (Beckman 
Instruments, Inc., Palo Alto, Calif.).  The sera were sterilized by membrane filtration and stored at 
-20°C  in 0.1-ml samples. The alloantisera were diluted as indicated in Hanks' balanced salt solution 
lacking  sodium  bicarbonate  (HBSS)  and  50  ul  were  added  to  cultures  without  complement. 
Cytotoxicity titers of the four polyspecific alloantisera against 51Cr-labeled donor strain spleen cells 
were comparable. The DBA anti-C57BL/6 serum had negligible activity against SJL spleen cells; the 
C3H anti-SJL serum had neglibible activity against C57BL/6 spleen cells. The alloantisera against 
antigens coded for by defined regions of the H-2 complex were diluted so that cytotoxicity titers were 
comparable when tested against spleen cells from the appropriate strains of mice. The one exception 
was the A.TL anti-A.TH serum which was from an early bleeding in the immunization schedule and 
had no detectable cytotoxic activity against SJL,  B10.S,  or A.Sw spleen cells. However, since this 
serum had activity against A/J thymocytes due to anti-TL antibodies, it was exhaustively absorbed 
with A/J thymocytes before centrifugation and filtration. 
Spleen  Cell  Cultures  and  PFC  Assays.  Dispersed,  single  spleen  cells  or  separated  splenic 
lymphoid cells at 10  ×  106 cells/ml in completely supplemented Eagle's minimal essential medium PIERCE,  KAPP,  SOLLIDAY, DORF,  AND BENACERRAF  923 
containing 10% fetal bovine serum (lot H73212, Reheis Chemical Co., Kankakee, Ill.) were incubated 
with or without  105  splenic adherent ceils or 7  x  104  peritoneal exudate M¢ and antigens under 
modified Mishell-Dutton conditions (10).  Cultures were stimulated with 107 SRBC,  10 ttg GAT, or 
GAT  bound  to  M~  and  alloantisera  were  added  according to  the  experimental protocol.  PFC 
responses to SRBC or GAT were measured after 5-days incubation using the modifications of the 
Jerne hemolytic plaque assay described previously (10, 11). Data are expressed as PFC per culture or 
as the mean of the percent of control responses, calculated as follows: (PFC/culture:alloantiserum 
treated  +  PFC/culture:untreated)  x  100  from three to five experiments. The range of individual 
values around the mean did not exceed 15%. 
Preparation  of Splenic  Lymphoid  Cells and Splenic  and  Peritoneal  Exudate M4).  Spleen cell 
suspensions were separated into splenic M~ and lymphoid cell populations by serial passage over 
plastic Petri dishes (1).  Depending on the experimental protocol, the separated populations were 
either recombined in  the  presence of antigen and  alloantiserum immediately or  incubated with 
alloantiserum  for  24  h,  washed  with  HBSS,  and  then  recombined in  the  presence of antigen. 
Peritoneal exudate M~b were collected from mice injected i.p. 3 days before with 1-ml sterile 10% 
proteose peptone broth (6,  12). 
Preparation ofMg)-Bound  GA T.  The preparation of GAT-M~b has been described previously (12). 
Briefly, 4  x  106 peritoneal exudate M~b in 2 ml HBSS were reacted with 200 ttg GAT containing 2 
#g[~2~I]GAT for 30 min at 4°C. In some experiments a portion of the macrophages were reacted with 
alloantiserum (final dilution 1/100) at 4°C for 30 min before the addition of GAT or M~b were reacted 
with alloantiserum but not with GAT. All M4~ preparations were held at 4°C for an equal period of 
time. 
The M~b were then washed three times with 50 ml HBSS and resuspended in HBSS at 7  x  10 ~ 
M¢/ml. The radioactivity in a portion of each M4) preparation was counted in a Packard autogamma 
scintillation counter (Packard Instrument Co., Inc., Downers Grove, Ill.)  and the amount of GAT 
bound to 7 ×  104 M~ was calculated. 7 z  104 M¢ in 0.1 ml HBSS were added to cultures of 10  z  10 ~ 
splenic lymphoid cells according to the experimental protocol. 
Cell  Counts.  Nucleated  cells  were  enumerated  with  a  Model  B  Coulter  Counter  (Coulter 
Electronics, Inc.,  Fine Particle Div.,  Hialeah,  Fla.).  Cell viability was determined by trypan blue 
exclusion with a  Cytograf Model 6300A (Bio/physics Systems, Inc., Mahopae, N. Y.). 
Results 
Effects  of Polyspecific  Alloantisera  against  Leukocyte  Alloantigens  on PFC 
Responses In Vitro.  Cultures of spleen cells from normal C57BL/6 and DBA/2 
mice  were  stimulated  with  SRBC;  DBA/2  anti-C57BL/6  serum  was  added  at 
various final dilutions at culture initiation. Day 5 IgM and IgG PFC responses in 
alloantiserum-treated  cultures  are  expressed  as  the  percent  of  responses  in 
control  cultures  to  which  no  alloantiserum  was  added  (Fig.  1).  The  DBA/2 
anti-C57BL/6 serum suppressed both IgM  and IgG PFC  responses by C57BL/6 
spleen cells 75% or more at final dilutions from  1/20 to 1/160. As the serum was 
diluted further,  the suppressive  effect  disappeared;  significant enhancement of 
PFC responses was not observed with any serum dilution. The alloantiserum did 
not significantly affect IgM and IgG (data not shown) PFC responses by DBA/2 
spleen  cells.  Viable  cell  recovery  in  all  cultures  was  approximately  2  x  106 
cells/culture.  Identical  titration experiments  using the other three polyspecific 
alloantisera  showed  that  the  alloantisera  had  no  significant  effect  on  PFC 
responses  by  spleen  cells  from  the  strain  of  mice  in  which  the  serum  was 
prepared. Results completely analogous with those in Fig.  1 were obtained when 
alloantisera were added to cultures of spleen cells from the mouse strains against 
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Portions of each of the four polyspecific alloantisera were absorbed three times 
at  4°C  for  30  min  with  ethylchloroformate  insolubilized  (13)  Ig  (1  mg  Ig/ml 
serum/absorption)  or  spleen  cells  (1  ml  cells/ml  serum/absorption)  from  the 
mouse  strain  in  which  the serum was prepared or against which  the serum was 
directed.  The  sera  were  added  to  cultures  of spleen  cells  from  mouse  strains 
against  which  the  alloantiserum  was  directed  at  a  final  dilution  of  1/100  at 
initiation.  The  results  were  identical  for all  four polyspecific alloantisera;  only 
absorption with spleen cells from the mouse strain against which the serum was 
directed removed the  suppressive activity from the  alloantisera. 
Effects  of AUoantiserum Added after Culture Initiation on PFC Responses In 
Vitro.  Cultures  of  spleen  cells  from  strains  of  mice  against  which  the  four 
polyspecific  alloantisera  were  directed  were  established  and  the  alloantiserum 
was added at a  final dilution  of 1/100 at initiation  or at 24-h intervals thereafter. 
IgM  and  IgG  PFC  responses  were  determined  at  120  h.  Results  of  all  these 
DBA/2 ANTI-C57BL /6  (F/no/  D//u/ion) 
Fro.  1.  Effects of various dilutions of DBA/2 anti-C57BL/6 serum added at culture initiation 
on PFC responses by C57BL/6 and DBA/2 spleen cells. 
experiments  were  comparable;  data  using  DBA/2  anti-C57BL/6  serum  in 
cultures  of  C57BL/6  spleen  cells  were  exemplary  (Fig.  2).  When  the  alloan- 
t/serum  was  added  at  culture  initiation,  IgM  and  IgG  PFC  responses  were 
suppressed  80%  or  more.  As  the  interval  after  culture  initiation  when  the 
alloantiserum  was  added  increased,  suppression  of the  PFC  responses  progres- 
sively  decreased.  Alloantiserum  added  at  72  h  had  no  effect  on  IgM  PFC 
responses,  but  IgG responses  were  still  suppressed  approximately 40%;  alloan- 
t/serum  added  at  96  h  had  no  effect  on  IgM  or  IgG PFC  responses.  In  other 
experiments, comparison of the kinetics of IgM and IgG PFC responses in control 
cultures  and  cultures  to  which  alloantiserum  was  added  at  initiation  clearly 
demonstrated  that  the  80%  or greater suppression  of 5-day PFC  responses  was 
due to a  failure to successfully initiate  the PFC  responses. 
Effect  of Removing  Noncell-Bound  Alloantibodies  after  Various Intervals  of 
Incubation  on PFC Responses In Vitro.  Cultures of spleen cells from strains of PIERCE, KAPP, SOLLIDAY, DORF, AND BENACERRAF  925 
mice  against  which  the  four  polyspecific  alloantisera  were  directed  were 
established and the alloantiserum was added to one-half of the cultures at a final 
dilution  of 1/25  at  culture initiation.  At  various  intervals  control and  alloan- 
tiserum-treated cultures  were  harvested,  spleen  cells  were washed  twice  with 
HBSS,  resuspended  in  fresh  medium  at  10  ×  106  cells/ml,  and  returned  to 
original culture dishes.  Cells  adherent to these dishes  had  been washed twice 
with HBSS. PFC assays were performed on day 5.  The data from experiments 
using the four polyspecific antisera were entirely comparable; results with DBA/2 
anti-C57BL/6 serum  are shown  (Fig.  3). PFC responses in cultures exposed to 
alloantiserum  for  48  h  were  suppressed  to  the  same  degree  as  responses  in 
cultures exposed to alloantiserum for 120 h. Exposure to alloantiserum for 24 h 
resulted in slightly less  suppression than  exposure for 48  h;  a  6-h exposure to 
alloantiserum had no significant effect on PFC responses. 
In other experiments not shown here, we examined whether spleen cells were 
HOUR DBA/2 ANTI-C57BL/6 (I/IOO)  ADDED 
Fla.  2,  Effects of DBA/2 anti-C57BL/6 serum added at intervals after culture initiation on 
PFC responses by C57BL/6 spleen cells. 
rendered  totally  incapable  of  developing  a  PFC  response  after  exposure  to 
alloantiserum  for 48  h.  The  results  clearly indicated  that  the  alloantiserum- 
mediated  suppression  of PFC  responses  was  not  the  result  of an  irreversible 
inactivation  of responding  spleen  cells.  Rather,  spleen  cells  after removal of 
alloantiserum at 48 h developed significantly greater PFC responses than spleen 
cells  continuously exposed to  alloantiserum  when  the  incubation  period  was 
extended to 7 days. 
Effect of Polyspecific AUoantisera  on PFC Responses In Vitro  by Spleen Cells 
from Various Mouse Strains.  The effects of the four polyspecific alloantisera on 
PFC  responses  by  spleen  cells  from  several  mouse  strains  were  examined to 
determine  whether  suppression  was  mediated  by  antibodies  against  antigens 
encoded by the H-2 complex only or whether antibodies to non-H-2 antigens were 
also involved and whether antibodies to antigens of one H-2 haplotype in an F I 
hybrid  were  capable  of  mediating  suppression  (Table I).  First,  each  serum 926  IMMUNE  RESPONSES  IN  VITRO.  XI 
suppressed IgM and IgG PFC responses by spleen cells from the mouse strains 
against which it was directed; none suppressed responses by A/J spleen cells even 
though  both  anti-SJL  sera  contained  antibodies  reactive  with  A/J  cells  by 
hemagglutination.  The two sera against SJL antigens suppressed PFC responses 
by A.Sw spleen cells (H-2  ~  haplotype on the A strain background) indicating that 
antibody against H-2 antigens can effectively mediate the suppression. However, 
all four antisera  suppressed responses by B10.S spleen cells (H-2  ~ haplotype on 
the C57BL/10 background)  and the DBA/2 anti-C57BL/6 serum suppressed PFC 
responses by B10.D2n spleen cells (H-2  a haplotype on the C57BL/10 background) 
(data  not shown). These data indicate that  antibody to non-H-2 as well as H-2 
antigens can mediate the suppression. This is especially evident in the case of the 
SJL  anti-C57BL/6  serum  which  should  be  reactive  against  only  the  non-H-2 
antigens on B10.S spleen cells and the C57BL/6 anti-SJL serum which should be 
HOURS EXPOSED TO DBA/2 ANTI-C57BL/6 (1/25) 
Fro.  3.  Effects of removing noncell-bound DBA/2 anti-C57BL/6 serum after various intervals 
on PFC responses by C57BL/6 spleen cells. The alloantiserum was added at culture initiation 
at  a  final dilution of 1/25. 
primarily  reactive with the  H-28 antigens  on B10.S spleen cells.  Suppression of 
responses  by  (C57BL/6  ×  SJL)F~  spleen  cells by all  four alloantisera  demon- 
strated that antibody against the antigens contributed by either parent in the F~ 
hybrid  can  effectively suppress PFC  responses.  The  last  two F1  hybrid strains 
(C57BL/6  ×  B10.S)FI and  (B10.A  ×  B10.S)F~ reiterate  all the previous points 
about suppression of PFC responses by alloantiserum. That is, antibody against 
H-2  and  non-H-2  antigens  can  mediate  suppression  and  antibody  against 
antigens  of only one  parent  on  F~ hybrid  spleen  cells is  sufficient to suppress 
IgM and IgG PFC responses. 
Effect of AUoantisera  against Antigens  Coded for by Defined Regions  of the 
H-2 Complex on PFC Responses In Vitro.  The effects of the alloantisera against 
antigens coded for by defined regions of the H-2 complex on 5-day PFC responses 
by spleen cells from  several strains  of mice were determined  (Table II).  These 
sera were added to cultures at initiation  at a final dilution of 1/50 which did not 
affect viable cell recovery. Two sera against serological specificity 33 of the H-2  ~ 
K  region,  which theoretically also could have activity against I region antigens, PIERCE,  KAPP,  SOLLIDAY,  DORF,  AND BENACERRAF  927 
effectively suppressed IgM and IgG PFC responses by C57BL/6 spleen cells but 
did not suppress responses by SJL or B10.S spleen cells. These sera suppressed 
responses by (C57BL/6  x  B10.S)F1 spleen cells approximately 50%.  One serum 
against serological specificity 19 of the H-2  ~ K  region, which theoretically could 
also  have  activity  against  S  region  antigens,  suppressed  IgM  and  IgG  PFC 
TABLE I 
Effect of Polyspecific Alloantisera on PFC Responses In Vitro by Spleen Cells from 
Various  Mouse Strains 
Mouse strain 
Percent control response {mean from five experiments) 
DBA/2  CsH  SJL  C57BL/6 
anti-C57BL/6*  anti-SJL*  anti-C57BL/6*  anti-SJL* 
C57BL/6  MS  24  93  30  129 
G  12  89  14  108 
SJL  M  119  33  107  30 
G  89  13  87  18 
A/J  M  93  117  122  107 
G  109  103  96  97 
A.Sw  M  111  27  109  24 
G  138  23  108  23 
B10.S  M  24  29  19  30 
G  10  14  16  19 
(C57BL/6 x  SJL)FI  M  19  21  25  3O 
G  24  15  19  24 
(C57BL/6 × B10.S)F1  M  20  30  19  30 
G  20  20  16  19 
(B10.A × B10.S)F1  M  24  40  22  31 
G  17  24  19  20 
* Final dilution of alloantiserum in cultures was 1/100. 
S M, IgM; G, IgG PFC response. 
responses by SJL,  B10.S,  and  (C57BL/6  ×  B10.S)F1  spleen cells but failed to 
suppress  responses  by  C57BL/6  spleen  cells.  The  A.TL  anti-A.TH  serum, 
theoretically reactive against  H-2  s  I region alloantigens,  selectively suppressed 
only IgG PFC  responses by SJL, B10.S,  and (C57BL/6  x  B10.S)F1 spleen cells 
about 50% and had no effect on PFC responses by C57BL/6 spleen cells. Adding 
this serum to cultures in higher concentrations resulted in significant toxicity, 
thus precluding further analysis of the phenomenon. The remaining alloantisera, 
reactive against serological specificities of the H-2  ~ D  region, failed to suppress 
responses  in  any  of the  spleen  cell  cultures.  In  other  experiments  (data  not 928  IMMUNE RESPONSES IN VITRO.  XI 
TABLE II 
Effect of AUoantisera Against Alloantigens Coded for by Defined  Regions of the H-2 
Complex  on PFC Responses  In Vitro by Spleen Cells from  Various Mouse Strains 
Percent control response (mean from five experiments) 
(C57BL/6  Alloantisemm*  C57BL/6  SJL  B10.S 
x B10.S)F~ 
MS  G  M  G  M  G  M  G 
Anti-33, ? 19  16  13  88  89  134  173  44  45 
Anti-33, ? I JJ  37  38  97  109  122  102  53  50 
Anti-19, ? S¶  103  111  40  28  37  29  38  37 
Anti-I**  103  96  117  51  85  44  87  56 
Anti-13, 28, 29,305~  131  146  127  108  117  121  --  -- 
Anti-299  102  116  104  86  110  99  127  109 
Anti-2, ?S, IJJ JJ  144  119  70  83  126  137  131  113 
Anti-2, ? non-H-2¶ ~  121  125  131  111  131  107  --  -- 
Anti-19, ?S + anti .......  18  11 
33, ?I9 
The H-2 complex*** 
Haplotype  K region  I region  S region  D region 
H-2  ~  33 (35, 36)$$$  b  h/o  2(5, 6, 27, 28, 29) 
H-2  ~  19 (5)  s  h/a  12(1, 3, 6, 7, 36, 42) 
* Final dilution of alloantiserum in cultures was 1/50. 
M, IgM; G, IgG PFC response. 
9 (B10.D2  x  A)F1 anti-B10.A (5R), D. Shreffler. 
II (B10.D2  x  A)F1  anti-B10.A (5R),  G. Snell. 
¶ A anti-A.TL, D. Shreffler. 
** A.TL anti-A.TH (early bleeding, absorbed with A/J thymocytes), D. Shreffler. 
$¢ (AKR x  A.CA)F, anti-AKR.M, G. Snell. 
99 (B10.D2  x  A)FI anti-HTH, D. Shreffler. 
Illl (B10.D2  ×  A)F~ anti-B10.A(4R), D. Shreffler. 
¶¶ (Balb/C  x  [C  x  BD]F~ anti-HTG, G. Snell. 
*** Modified from: J. Klein and D. C. Shreffler. 1971. The H-2 model for the major histocompatibility 
systems. Transplant. Rev. 6:3. J. Klein, P. Demant, F. Festenstein, H. O. McDevitt, D. C. Shreffler, 
G. D.  Snell, and J.  H. Stimpfling. 1974. Genetic nomenclature for the H-2 complex of the mouse. 
Immunogenetics. In press. 
$$$ The public serological H-2 specificities for K  and D regions are in parentheses. 
shown),  another  high  titer  alloantiserum  against  H-2  ~  D  region  serological 
specificities  failed  to  suppress  PFC  responses  by  A/J  spleen  cells.  When  the 
"anti-19"  and  "anti-33"  sera  were  both  added  to  cultures  of  (C57BL/6  x 
B10.S)F1  spleen  cells at  dilutions  of 1/50  the  suppression  of PFC  responses  was 
greater  than  when  either  serum  was  added  alone  at  a  dilution  of 1/50  or  1/25. 
Cellular Site of Action of Alloantiserum  in Suppression of PFC Responses to 
SRBC  In  Vitro.  To  analyze  the  cellular  sites  of  action  of  the  suppressive 
alloantisera,  M~b  and  lymphoid  cells were  separated  from  suspensions  of spleen PIERCE,  KAPP,  SOLLIDAY, DORF,  AND BENACERRAF  929 
cells from  C57BL/6 (H-2~),  SJL  (H-28),  and  (C57BL/6  ×  SJL)F1  (H-2  b/8) mice 
and recombined in all the possible combinations.  The cultures were stimulated 
with  10 ~ SRBC  and  DBA/2  anti-C57BL/6  (anti-b)  or  C3H  anti-SJL  (anti-s) 
serum  (final  dilution,  1/100)  was  added  to  one-third  the  cultures  of  each 
combination  at  initiation.  Day 5 IgM and IgG PFC responses are expressed as 
percent  control  response  (Fig.  4).  First,  [gM  and  IgG  PFC  responses  were 
suppressed by the  alloantiserum  directed against  alloantigens  on both the M¢ 
and  lymphoid  cells but  not  by the  irrelevant  alloantiserum  (groups I  and  II). 
Second, when the Me and lymphoid cells were from H-2  b/s F1 hybrid mice, the 
anti-b  and  anti-s  alloantisera  both  suppressed  IgM  and  IgG  PFC  responses 
(group III). In all the remaining  combinations of Me and lymphoid cells, when 
the alloantiserum  was directed against  alloantigens  only on Me,  both IgM and 
IgG responses were suppressed.  However, when  alloantigens  only on lymphoid 
cells  were  the  target  of  the  alloantiserum,  IgG  responses  were  selectively 
suppressed. In some combinations of M~b and  lymphoid cells, the target cell of 
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Fro.  4.  Suppression of PFC responses by alloantisera against leukocyte alloantigens: site of 
action. M~b and lymphoid cells from C57BL/6 (b), SJL (s) and (C57BL/6  × SJL)FL (b/s) mice 
were incubated  in  indicated combinations; DBA/2 anti-C57BL/6  (anti-b)  or C3H  anti-SJL 
(anti-s) serum was added to one-third of the cultures at initiation at a final dilution of 1/100. 
Day 5 PFC responses are expressed as percent control responses in untreated cultures. 930  IMMUNE  RESPONSES  IN  VITRO.  XI 
the  alloantiserum could not be  determined with certainty, e.g.  groups VI and 
VIII,  cultures with the anti-b serum,  or groups VII and IX,  cultures with the 
anti-s  serum.  Although  not  evident  from  this  figure,  each  lymphoid  cell 
population  developed  comparable  PFC  responses  in  control  cultures  when 
incubated with syngeneic or allogeneic M~b. Also, none of the separated M~b or 
lymphoid cell populations alone developed significant PFC responses (data not 
shown). Thus, alloantisera can apparently suppress PFC responses by interfering 
with the functions of macrophages or by interfering with the interactions among 
T  and B cells which are so crucial for development of IgG responses. 
In a modification of this approach, separated C57BL/6 MO and lymphoid cells 
were incubated with or without DBA/2 anti-C57BL/6 serum at a final dilution of 
1/25 for 24 h. Then, the lymphoid cells were harvested, washed, adjusted to 10 × 
106 cells/ml, and added with 107 SRBC to appropriate dishes containing adherent 
M~b  which  had  also  been  washed  with  HBSS.  Cultures  of' normal  or  alloan- 
tiserum-treated  M~  or  lymphoid  cells  incubated  alone  with  SRBC  failed  to 
develop significant 5-day IgM or IgG PFC responses  (Table III). Responses by 
alloantiserum-treated M~b and lymphoid cells were effectively suppressed when 
compared to responses by normal Me and lymphoid cells. When alloantiserum- 
treated  Me  were  incubated  with  normal  lymphoid cells,  IgM  and  IgG  PFC 
responses were suppressed to the same degree as responses in cultures where both 
M~b  and  lymphoid cells had been  treated with the alloantiserum. In contrast, 
TABLE III 
Suppression of Plaque-Forming Cell Responses to SRBC In Vitro 
by Alloantiserum:  Site of Action 
Culture variables:  PFC/culture* 
10 x  106 
105 C57BL/6 
C57BL/6  IgM  IgG  Me  lymphoid  cells 
Normal$  Normal  1,850 (100)§  555 (100) 
Normal  --  22 (<1)  3 (<1) 
Treated$  --  18 (<1)  5 (<1) 
--  Normal  185  (12)  38  (7) 
--  Treated  142  (7)  30  {5) 
Treated  Treated  655  (35)  215  (42) 
Treated  Normal  770  (41)  235  (41) 
Normal  Treated  1,600  (86)  525  (92) 
* PFC/culture on day 5 from a  representative experiment. 
Separated  C57BL/6  Me  and  lymphoid  cells  were  incubated  without 
(normal)  or with (treated)  DBA/2 anti-C57BL/6 serum at a  final dilution 
of 1/25 for 24 h. Me  adherent to culture dishes were washed with HBSS; 
lymphoid  cells  were  harvested,  washed,  adjusted  to  10  ×  106/ml,  and 
added to appropriate dishes containing M~b and 107 SRBC. The numbers 
of M¢ in normal and treated culture dishes were comparable. 
§ The numbers in parentheses are the mean percent of control responses 
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cultures  of  normal  M~b  and  alloantiserum-treated  lymphoid  cells  developed 
responses which were not significantly suppressed. Viable cell recovery from all 
cultures was approximately 2 ×  106 cells. Thus, a 24-h exposure to alloantiserum 
renders Me  incapable of supporting development of PFC  responses,  whereas, 
lymphoid cells similarly exposed are able to develop normal responses. 
Effects  of AUoantiserum  on Antigen  Binding  by M4~  and  on  the Ability  of 
MC~-Bound Antigen to Stimulate PFC Responses In Vitro.  To further probe the 
sites and mechanisms of suppression of PFC responses by alloantiserum, we have 
used  GAT  as  our  antigen.  Antibody responses  to  GAT  are  controlled  by  an 
H-2-1inked immune response  (Ir)  gene which maps within the H-2 complex (8, 
14). Spleen cells from C57BL/6 mice, a responder strain, but not from SJL mice, 
a  nonresponder  strain,  develop  IgG  PFC  responses  to  GAT  in  vitro  (11). 
Furthermore, Me  from either C57BL/6 or  SJL mice which have been  reacted 
with  GAT  and  bear  nanogram  quantities  of  GAT  stimulate  comparable 
GAT-specific PFC  responses  by  responder  C57BL/6 lymphoid cells  (4).  Other 
studies have demonstrated that the defect in genetic nonresponder spleen cells is 
the  inability of their T  cells to provide appropriate helper function for B  cells 
which, however, can develop PFC responses to GAT under appropriate circum- 
stances (4, 8,  11,  15). 
Several features of alloantiserum-mediated suppression of GAT-specific PFC 
responses  by  C57BL/6  lymphoid cells  are  shown  in  Table  IV.  First,  7  ×  104 
C57BL/6 M¢ bearing 3.17 ng of GAT (Me pulsed with GAT as described in the 
Materials  and  Methods)  stimulated  GAT-specific  IgG  PFC  responses  by 
C57BL/6 lymphoid cells comparable in magnitude to responses stimulated by 10 
ttg  of soluble GAT (4,  12,  see also Table V).  This response was suppressed by 
antiserum  against  C57BL/6  alloantigens  but  not  by  antiserum  against  SJL 
alloantigens when the antiserum was added to cultures at initiation at a  final 
dilution of 1/100.  Second, when C57BL/6 Me were reacted with either DBA/2 
anti-C57BL/6 or C3H anti-SJL alloantiserum before and during the reaction with 
GAT,  the  amount  of  GAT  bound/7  ×  104  M¢  was  not  reduced.  However, 
GAT-M¢ which had been reacted with the anti-C57BL/6 alloantiserum failed to 
stimulate  a  PFC  response  by the  C57BL/6  lymphoid cells,  whereas  GAT-M~ 
which  had  been  reacted  with the  anti-SJL  alloantiserum  stimulated normal 
responses. Third, when alloantiserum-treated Me bearing no GAT were added to 
cultures of C57BL/6 lymphoid cells and GAT-M¢ which had not been reacted 
with alloantiserum, normal GAT-specific PFC responses developed. Viable cell 
recovery from all cultures was approximately 2  ×  10 ~ cells. These experiments 
allow  several  conclusions:  (a)  alloantiserum  does  not  interfere  with  antigen 
uptake  by  Me  but  does  interfere  with  the  ability of M¢-bound  antigen  to 
stimulate PFC responses; (b) alloantiserum does not interfere with the viability 
promoting function of M¢  (12);  and (c)  alloantiserum-mediated suppression is 
not  due  to  soluble  antigen-antibody complexes from Me  interfering with the 
responses of the lymphoid cells. 
The experiments shown in Table V further extend the analysis of the site of 
action of suppressive alloantiserum in the GAT system. As shown in the top half 
of the table, C57BL/6 M~ bearing 1.46 ng GAT and SJL Me bearing 0.92 ng GAT 932  IMMUNE  RESPONSES IN VITRO.  XI 
TABLE IV 
Effect of Alloantiserum on Antigen Binding by Macrophages and on the Ability of 
Macrophage-Bound Antigen to Stimulate Plaque-Forming Cell Responses In Vitro 
Culture variables: 
10 × l0 s C57BL/6 Lymphoid Cells* 
7 × 104  7 × 104 
7 ×  104  alloantiserum-  alloantiserum- 
GAT-M¢ §  treated  treated 
GAT-M¢[[  Me t 
Alloantiserum  GAT-specific IgG 
PFC/culture$ 
+  --  --  None  880  (100)** 
+  --  --  DBA anti-C5755 added  40  (6) 
to culture 
+  --  --  C3H anti-SJL~ added  740  (87) 
to culture 
--  +  (6.89 ng)  --  DBA anti-C57  0  (5) 
--  +  (5.44 ng)  --  C3H anti-SJL  730  (92) 
+  --  +  DBA anti-C57  830  (97) 
+  --  +  C3H anti-SJL  790  (90) 
* Lymphoid cells incubated with 10 ug soluble GAT failed to develop significant PFC responses. 
GAT-specific PFC/culture on day 5 from a representative experiment. 
§ C57BL/6 peritoneal exudate Me were pulsed with GAT as described in the Materials and Methods; 
in this experiment 7  ×  104 Me bound 3.17 ng GAT. 
n M~b were reacted with the indicated  alloantiserum at a  final dilution of 1/100 at 4°C for 30 min 
before reaction with GAT. Thereafter, Me were treated as described in the Materials and Methods; 
numbers in parentheses are the ng of GAT/7  x  104 M4~. 
~! Me were treated  with the indicated  alloantiserum as described above but were not pulsed with 
GAT. 
** The numbers  in parentheses  are the mean percent of control responses from three experiments. 
~c$ Alloantiserum added to these cultures at initiation at a final dilution of 1/100. 
stimulated  comparable  PFC  responses  by  C57BL/6  lymphoid  cells.  Anti- 
C57BL/6  but  not anti-SJL  alloantiserum  suppressed  the response  stimulated  by 
C57BL/6  GAT-Mq~.  However,  when  SJL  GAT-M¢  were  used,  both  alloantisera 
suppressed  the PFC  response.  In the case of the anti-C57BL/6  alloantiserum,  the 
site  of  action  can  only  be  the  lymphoid  cells,  whereas  with  the  anti-SJL 
altoantiserum,  the  only  site  of action  can  be  at  the  GAT-M¢.  The  experiment 
shown  in  the  bottom  half of the table  illustrates  that  Me  after brief exposure  to 
alloantiserum  which  reacts  with  membrane  alloantigens  did  not  recover  the 
ability  to  present  antigen  in  a  manner  which  stimulated  PFC  responses  by the 
lymphoid  cells. 
Discussion 
These  experiments  document  several of the salient  features  about  the phenome- 
nology  and  mechanisms  involved  in  the  suppression  of PFC  responses  to SRBC 
and  GAT  by mouse  spleen in vitro by alloantisera  against  leukocyte  alloantigens. PIERCE,  KAPP, SOLLIDAY, DORF, AND  BENACERRAF  933 
These experiments demonstrate that alloantisera against antigens encoded by K 
and I region genes of the H-2 complex, and antisera  to non-H-2 antigens,  either 
minor histocompatibility antigens or other leukocyte alloantigens can effectively 
suppress PFC responses in vitro. Furthermore, these alloantisera suppressed both 
IgM  and  IgG  PFC  responses  when  directed  against  alloantigens  on  MO,  but 
suppressed only IgG responses when directed against antigens on lymphoid cells. 
These experiments further emphasize the importance of membrane alloantigens 
in mediating the interactions  among antigen,  M~b, T  cells, and B cells which are 
so  crucial  for  the  initiation  of PFC  responses  to  complex,  multideterminant 
antigens  in vitro.  The  mode of action of these suppressive alloantisera,  from a 
TABLE V 
Suppression  of Plaque-Forming  Cell Responses  to GAT In Vitro 
by AUoantiserum:  Site of Action 
Culture variables: 
10  x  10 e C57BL/6 lymphoid cells* 
7 x  104  Alloantiserum 
GAT-MO§  added to culturejJ 
GAT-specific 
IgG PFC/Culture¢ 
C57  None  305  (100)  ¶ 
C57  DBA anti-C57  35  (13) 
C57  C3H anti-SJL  340 (115) 
SJL  None  380 (100) 
SJL  DBA anti-C57  80  (25) 
SJL  C3H anti-SJL  40  (12) 
10ttgof 
7 x  104 M~b  Me pretreatment**  GAT 
C57  None  ÷  565  (100) 
C57  DBA anti-C57  +  30  (7) 
C57  C3H antLSJL  +  455  (85) 
SJL  None  +  425  (100) 
SJL  DBA anti-C57  +  605  (133) 
SJL  C3H anti-SJL  +  0  (6) 
* Separated lymphoid cells incubated with 10 #g GAT failed to develop 
significant PFC responses. 
GAT-specific PFC/culture on day 5 from a representative experiment. 
§ C57BL/6 or SJL peritoneal exudate M¢ were pulsed with GAT; in this 
experiment there were 1.46  ng GAT/7  x  104  C57BL/6  MO  and 0.92  ng 
GAT/7  x  104 SJL M¢. 
II Alloantiserum was added to cultures at initiation at a final dilution of 
i/I00. 
¶ The numbers in parentheses are the mean percent of control responses 
from three experiments. 
** M~ were reacted with the indicated alloantiserum at a final dilution of 
1/100 at 4°C for 30 min, washed, and 7 x  104 M~ were added to cultures in 
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phenomenological point of view, is not unlike that of anti-u-chain antisera (16), 
and antibody to the stimulating antigen (10),  both of which mediate their effect 
early  in  a  specific,  noncytotoxic  fashion  and  interfere  with  the  successful 
initiation of the immune response. The possibility that alloantisera suppress PFC 
responses in a nonspecific fashion by combining with any membrane alloantigens 
on  responding  spleen  cells  and  producing  membrane  perturbations  which 
preclude  development  of immune  responses  can  be  ruled  out  since  antisera 
against H-2D region alloantigens failed to suppress responses. 
In view of the demonstrated critical importance of molecules encoded by the K 
and  I  regions  of  the  H-2  complex  in  determining  successful  physiologic 
cooperation between T  cells and B  cells in antibody responses  (7,  8),  we were 
somewhat  surprised  that  antibodies  against  non-H-2  alloantigens  could  also 
effectively suppress  FPC  responses  in  vitro.  Furthermore,  the  effects  of the 
various  alloantisera  on  PFC  responses  by  F~  hybrid  spleen  cells  were  also 
unexpected in the sense that they suggest that the H-2 and non-H-2 alloantigens 
on  F~  hybrid  cells  which  have  not  reacted  with alloantiserum are  unable  to 
mediate the cell interactions required for development of PFC responses. The 
fact  that the  polyspecific alloantisera suppressed  responses  by F1  hybrid and 
parental spleen  cells  to  the  same degree,  whereas,  antisera to K  and I region 
alloantigens suppressed responses by F1 hybrid spleen cells less efficiently than 
responses by parental spleen cells at the same serum dilution may be due to the 
different titers and immunoglobulin classes of the various antisera or to the fact 
that the polyspecific antisera reacted with non-H-2 as well as H-2 antigens. If the 
latter is true, it suggests that non-H-2 alloantigens may play a more significant 
role in mediating the essential cell interactions in the development of antibody 
responses than has previously been realized. Studies to determine the identity 
and function(s) of such  non-H-2 alloantigens in  the development of antibody 
responses are in progress. 
The  polyspecific  antisera  against  H-2  and  non-H-2  alloantigens  and  the 
antisera specific for K  region alloantigens suppressed  both IgM and IgG PFC 
responses  suggesting that  these  antisera  are  interfering with  cell  interactions 
which are fundamental to the development of all antibody responses. In contrast, 
the antiserum against alloantigens coded for by only the I region of H-2  s (A.TL 
anti-A.TH) selectively suppressed IgG PFC responses by H-2  ~ spleen cells. Since 
this  antiserum  had  no  effect on  IgM  PFC  responses,  it  seems  likely that  its 
mechanism(s) of action is quite different from that of the other alloantisera.  2 
The  observations  that  the  polyspecific  alloantisera  interfere  in  a  rather 
long-lasting fashion with the ability of M~b to stimulate development of both IgM 
and IgG PFC response, but not at all with their ability to bind antigen or their 
viability promoting function (12), may account for the ability of these antisera to 
prevent  successful  initiation  of the  antibody responses.  Why are  the  alloan- 
tiserum-treated Me with associated antigen unable to stimulate lymphoid cells 
to develop an antibody response? One possibility is that the membrane of the 
antigen-bearing Me must have a "freedom of movement" to effectively  stimulate 
2  Detailed  investigations on the suppressive effects of A.TL anti-A.TH sera obtained from latter 
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lymphoid cells and that the alloantiserum restricts this freedom. It has also  been 
suggested that the  relevant M~b-associated antigen must first be endocytosed, 
partially degraded in phagolysosomes,  and returned to the membrane before it is 
effectively immunogenic (17). Thus, the alloantiserum could interfere with this 
phase of antigen handling by Me. 
In addition  to interfering with M~ handling of antigen, alloantiserum could 
also block the appropriate required interactions of M~b with T and B cells. In this 
sense, the  suppression of PFC  responses we observe may be analogous to the 
alloantiserum-mediated  inhibition of antigen-specific DNA synthetic responses 
by guinea pig lymphocytes (18). In that experimental system, alloantiserum can 
suppress by interfering with the function of the receptor for antigen on T cells, or 
by interfering with interactions between antigen-bearing M~ and T cells which 
are  controlled by  gene products  of  the  major  histocompatibility  complex 
including Ir genes (19, 20). In the guinea pig, MO and T cells must be syngeneic 
for successful development of DNA synthetic responses to antigen (19), whereas, 
in the mouse, it is the T and B cells, and not the M~b, which must be syngeneic  or 
semisyngeneic for  successful development  of  antibody  responses (8). These 
differences  in  the  requirements  for  syngenicity of  MO  and  the  responding 
lymphoid cells may depend on  which type of lymphoid cell response is being 
measured and  its sensitivity to activation.  For DNA synthetic responses by T 
cells, it may be that M~b and T cells must be syngeneic for optimal activation ofT 
cells to proceed. Similarly, for antibody responses by B cells, it may be that T 
and B cells must be syngeneic for effective triggering of the  B cells to occur. 
However, allogeneic M~ may be able to activate T cells sufficiently for effective 
cooperation with syngeneic B cells, but not for development of DNA synthetic 
responses. 
Whether it is the T cell, B cell, or the interactions among these two cells which 
is the site of action of the polyspecific alloantisera on the lymphoid cells cannot 
be discerned from the present data.  However, the selective suppression of lgG 
responses by  antisera  against alloantigens  on  lymphoid cells indicates  that 
interactions involved in the generation of IgG responses are affected more than 
interactions involved with IgM responses. Two mechanisms can be dismissed: (a) 
the alloantiserum is not interfering with antigen recognition by B cells, since this 
function  is  mediated  by immunoglobulin receptors (16, 21), and  normal IgM 
responses do develop; and  (b) the  alloantiserum  is probably not  activating  a 
population of nonspecific suppressor T cells, since such cells do not interfere with 
initiation of the PFC response (22) which the alloantiserum does. Furthermore, 
we have been  unable  to detect suppressor T-cell activity  after  interaction  of 
spleen cells with these alloantisera. 3 
It is conceivable that the alloantisera interfere with antigen recognition by T 
cells. The  precise nature  of the  T-cell receptor for antigen is  still  unknown; 
immunoglobulin, possibly a monomeric IgM molecule (21), and products of Ir 
genes  (8)  have been  proposed.  If Ir-gene products  are  the  receptors, these 
polyspecific alloantisera, which should be reactive with alloantigens coded for by 
the  I region of the  H-2 complex, could block antigen recognition directly by 
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interfering  with the function  of the receptor.  However, this  would be obtained 
only if the lr-gene product receptor and the target alloantigens were identical or 
were spatially related on the cell membrane.  If immunoglobulin  is the receptor 
and the alloantigens against which antisera are reactive are closely juxtaposed on 
the T-cell membrane,  the alloantisera could interfere with antigen recognition in 
a steric fashion. 
In  view of the requirement  that  T  and  B  cells must be syngeneic or at  least 
semisyngeneic for successful development of antibody responses (usually of the 
IgG class)  by B  cells,  it is highly likely that the alloantisera  act by interfering 
with the necessary interactions  between the T  cells and B cells. The membrane 
molecules involved in  these  interactions  could be H-2 antigens  or alloantigens 
coded  for  by  the  H-2  I  region  (Ia  antigens)  (8),  both  of  which  have  been 
demonstrated on membranes of T  and  B  cells (14,  23-26).  If the antisera react 
with antigens on T  cells, these cells may be unable to efficiently interact with B 
cells.  Alternatively,  if the alloantisera  interacts  with these antigens  on B  cells, 
which have  been proposed as the  "acceptor site" for the  second signal  from T 
cells (8), the T cells or their products so essential for stimulation of IgG responses 
would be denied access to the B cells and suppression of IgG responses would be 
the result.  The antisera  could also react with antigens on both T  and B cells to 
preclude their effective interaction. 
In  conclusion,  we  have  demonstrated  that  alloantisera  against  non-H-2 
alloantigens  and  alloantigens  coded  for  by the  K  region  of the  H-2  complex 
suppressed both IgM and IgG PFC responses in vitro, whereas, antisera  against 
alloantigens coded for by the I region selectively suppressed IgG PFC responses. 
The  polyspecific  alloantisera  used  in  this  study  may  contain  antibodies  to 
alloantigens  coded for by non-H-2,  H-2K, and H-2I region genes. Indeed,  Sachs 
and Cone (24) and David and Shreffler (27) have identified antibodies to I region 
antigens in conventional anti-H-2 alloantisera.  In view of the dual sites of action 
at the cellular level for suppressive activity of the polyspecific alloantisera which 
have  been  demonstrated  in  this  study,  it  is  reasonable  to  speculate  that  the 
antibodies  against  non-H-2  alloantigens  and  alloantigens  coded  for  by the  K 
region  of the H-2 complex which  suppress  both IgM  and  IgG responses act by 
interfering with Me function, while selective suppression of the IgG responses is 
due  to  antibody  to  I  region  alloantigens  which  affect  lymphocyte  function. 
Investigations of these possibilities are currently in progress. 
Summary 
The effects of alloantisera against leukocyte alloantigens on plaque-forming cell 
(PFC)  responses to sheep erythrocytes and the terpolymer of L-glutamic acid 6°- 
L-alanine3°-L-tyrosine 1° (GAT) by mouse spleen cells in vitro have been investi- 
gated.  Polyspecific antibodies against both H-2 and non-H-2 alloantigens on re- 
sponding  spleen  cells  suppressed  both  IgM  and  IgG  PFC  responses;  antisera 
against alloantigens coded for by the K and I regions, but not the D region, of the 
H-2  complex  also effectively suppressed  PFC  responses.  The  suppression  was 
not due to cytotoxicity to the spleen cells or anti-immunoglobulin activity in the PIERCE,  KAPP,  SOLLIDAY, DORF,  AND BENACERRAF  937 
sera and  was directly related to the amount of antiserum added  to the cultures. 
The suppression was specific for spleen cells against which the alloantiserum was 
directed.  The  alloantisera  suppressed  responses  most  effectively when  present 
during  the  first  24 h  of incubation,  and  although  not rendering  lymphoid cells 
incapable of developing PFC responses after removal of noncell-bound antibody, 
did  act  by  interfering  with  successful  initiation  of  the  PFC  response.  The 
alloantisera suppressed both IgM and IgG PFC responses when directed against 
alloantigens only on macrophages, but selectively suppressed IgG responses when 
directed  against  alloantigens  only on  lymphoid  cells.  The  alloantisera  did  not 
interfere with the ability of macrophages to bind GAT or to support the viability 
of the lymphoid cells, but did interfere with the ability of macrophage-associated 
antigen  to  effectively  stimulate  antibody  responses  by  the  lymphoid  cells. 
Possible  mechanisms  for  the  effects  of  alloantisera  on  macrophages  and  the 
selective  suppression  of IgG responses  when  the  antisera  are  directed  against 
alloantigens  on  lymphoid  cells  are  discussed  with  reference  to  our  current 
understanding  of genetic restrictions  governing cell interactions  in the develop- 
ment of antibody responses in mice. 
We thank Doctors George Snell and Donald Shreffler for their generous gifts of alloantiserum  against 
defined specificities of the H-2 complex. 
Received for publication 11 June 1974. 
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